Skip to main content
Caplight Logo









TICAROS Co., Ltd

TICAROS Co., Ltd

Private
SeoulHealthcare & Life Scienceshttp://ticaros.com/

Last Round

Series D

Mar 3, 2026

Est. Valuation

$197.42M

Total Funding Raised

$42.5M

Company Overview

TICAROS Co., Ltd is a biotechnology company that develops next-generation CAR-T and CAR-NK cell therapies for cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

CAR-T therapycell therapyimmunotherapycancer treatmentsolid tumor therapybiotechnologydrug discoveryclinical trialsprecision medicinenext-gen CAR-Tbiotech startupCDMOhematological malignancy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TICAROS Co., Ltd Comparables

Compare TICAROS Co., Ltd with similar companies based on industry and business-model similarity.

TICAROS Co., Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
InnoBation Bio
83%
Curocell
81%
AbClon Inc.
78%

TICAROS Co., Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMar 3, 2026
Series CAug 24, 2021
Series BJan 9, 2020
Series AFeb 1, 2019

TICAROS Co., Ltd Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 9, 2020

    $5.24M round led by Medytox Venture Investment.

TICAROS Co., Ltd Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TICAROS Co., Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TICAROS Co., Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Year Founded2018
Last FundingMar 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?